| Financial Year |
March 31 2023 |
| Monetary Funds |
407,396,278.89 |
| Held-for-trading Financial Assets |
131,397,125.03 |
| Notes Receivable |
37,960,239.47 |
| Accounts Receivable |
1,549,392,778.22 |
| Advances to Suppliers |
14,547,522.84 |
| Other Receivables |
63,157,999.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
464,414,258.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
293,980,318.54 |
| Other Current Assets |
59,669,802.21 |
| Total Current Assets |
3,319,419,790.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
856,045,788.74 |
| Long-term Equity Investment |
152,289,769.88 |
| Investment Properties |
23,267,046.79 |
| Fixed Assetes |
209,173,743.43 |
| Under-construction Projects |
180,010,552.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,137,499.73 |
| R&D expenses |
-- |
| Goodwill |
147,155,193.64 |
| Long-Term Deferred and Prepaid Expenses |
6,443,514.46 |
| Deferred Income Tax Assets |
134,427,293.97 |
| Other Non-Current Assets |
123,192,864.40 |
| Sub-Total of Non-Current Assets |
1,919,394,933.77 |
| Total Assets |
5,238,814,724.51 |
| Short-Term Loans |
218,599,704.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
144,980,597.08 |
| Accounts Payable |
904,496,895.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
93,883,077.41 |
| Taxes Payable |
16,444,298.46 |
| Interest Payable |
-- |
| Dividend Payable |
449,024.55 |
| Other payables |
158,518,689.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
41,491,386.52 |
| Other Current Liabilities |
116,420,065.69 |
| Sub-Total of Current Liabilities |
1,822,811,731.40 |
| Long-term Loans |
21,278,129.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
115,266,061.97 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,124,895.49 |
| Deferred Income Tax Liabilities |
48,379,761.05 |
| Other Non-Current Liabilities |
83,430,865.58 |
| Sub-Total of Non-Current Liabilities |
273,409,858.42 |
| Total Liabilities |
2,096,221,589.82 |
| Paid-In Capital(Or Share Stock) |
1,737,183,321.00 |
| Capital Surplus |
2,440,824,231.92 |
| Surplus Reserve |
120,611,789.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,201,524,923.55 |
| Minority Stockholder's Interest |
49,610,495.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,092,982,638.90 |
| Owner's Equity（Stockholder's Equity） |
3,142,593,134.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,238,814,724.51 |
